1. Thu YM, Van Riper S, Higgins L, Zhang T, Becker J, Markowski T, Nguyen HD, Griffin T, and Bielinsky A. 2016. Slx5/Slx8 promotes replication stress tolerance by facilitating mitotic progression. Cell Reports, 15, 1254-1265.
  2. Baxley R.M., Thu YM, Bielinsky A.K. 2016. Role of Mcm10 in replication initiation. The Initiation of DNA Replication in Eukaryotes (pp. 319-341). Editor: Dr. Daniel Kaplan. Publisher: Springer.
  3. Thu YM and Bielinsky A. 2014. MCM10: One tool for all-integrity, maintenance and damage control. Semin Cell Dev Biol, 30C: 121-130.
  4. Nguyen HD, Becker J*, Thu YM*, Costanzo M, Koch E, Smith S, Myung K, Myers C, Boone C, and Bielinsky A. 2013. Unligated Okazaki fragments induce PCNA ubiquitination and a requirement for Rad59-dependent replication fork progression. PLOS One, 8: e66379. *Equal contribution
  5. Thu YM and Bielinsky A. 2013. Enigmatic roles of Mcm10 in DNA replication. Trends in Biochemical Sciences, 38: 184-194.  
  6. Liu Y, Su Y, Hawkins O, Vilgelm A, Sobolik-Delmaire T, Thu YM, Kantrow S, Splittgerber R, Short S, Amiri K, Ecsedy J, Sosman J, Kelley M, and Richmond A. 2013. Targeting aurora kinases limits tumor growth through DNA damage-mediated senescence and blockade of NF-kB impairs this drug-induced senescence. EMBO Molecular Medicine, 5: 149-166.
  7. Thu YM, Su Y, Yang J, Splittgerber R, Na S, Boyd A, Mosse C, Simons C and Richmond A. 2011. NF-kB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the b-catenin pathway. Oncogene, 31: 2580-2592.
  8. Thu YM and Richmond A. 2010. NF-kB inducing kinase: a key regulator in the immune system and in cancer. Cytokine and Growth Factor Reviews, 21: 213-226.
  9. Yang J, Zaja-Milatovic S, Thu YM, Lee F, Smykla R and Richmond A. 2009. Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. Molecular Cancer Therapeutic, 8: 636-647.
  10. Dhawan P, Su Y, Thu YM, Yu Y, Baugher P, Ellis DL, Sobolik-Delmaire T, Kelly M, Cheung TC, Ware CF and Richmond A. The lymphotoxin-b receptor is an upstream activator of NF-κB-mediated transcription in melanoma cells. The Journal of Biological Chemistry, 283: 15399-15408.
  11. Raman D, Baugher P, Thu YM and Richmond A. 2007. Role of chemokines in tumor growth. The Cancer Letter. 256: 137-165.